Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy
Biotech
Industry disappointed as FDA reportedly puts Verdun on leave
The FDA has reportedly put the director of its cell and gene therapy office on administrative leave and escorted her out of the agency.
Nick Paul Taylor
Jun 20, 2025 1:53am
Fierce Pharma
BioNTech to wind down cell therapy manufacturing in Maryland
Jun 18, 2025 10:23am
As investors pivot from cell therapy, Immatics keeps the faith
Jun 6, 2025 3:50am
ASCO: Immatics cell therapy sees 56% ORR in advanced melanoma
May 31, 2025 8:00am
NIH nixes financing for Pluri's radiation exposure cell therapy
Apr 18, 2025 9:10am
Adaptimmune questions own longevity, axes preclinical funding
Mar 20, 2025 2:04pm
